This content is only available within our institutional offering.
24 Jan 2017
Revenue +30% for 2016; strong growth expected for 2017
Sign in
This content is only available to commercial clients. Sign in if you have access or contact support@research-tree.com to set up a commercial account
This content is only available to commercial clients. Sign in if you have access or contact support@research-tree.com to set up a commercial account
Revenue +30% for 2016; strong growth expected for 2017
MaxCyte, Inc. (MXCT:LON) | 313 0 0.0% | Mkt Cap: 325.9m
- Published:
24 Jan 2017 -
Author:
Dr Julie Simmonds -
Pages:
8